高危冠状动脉斑块的多模态血管内成像
综述指出,多数心梗由斑块破裂或糜烂引起,但现有临床冠脉成像无法可靠预测哪些斑块将导致心梗;目前技术多识别斑块形态特征,不能检测驱动未来风险的关键分子特征。工程、科学与临床人员正合作研发将两种或以上互补模态整合于同一导管的多模态血管内成像技术,部分已在早期临床研究中测试,其他下一代技术仍在开发中;本文从工程和临床角度审视这些新兴杂交冠脉内成像技术的优势、局限和临床转化潜力。
要点
- 现有临床冠脉成像无法可靠预测哪些斑块将导致心梗。
- 当前技术主要识别斑块形态特征,不能检测关键分子特征。
- 多模态血管内成像将两种以上互补模态整合于同一导管。
核心结论
- 现有临床冠脉成像均不能可靠预测哪些斑块将导致心梗,需发展能检测分子特征的多模态血管内成像。
研究设计与样本
- 综述,检索范围与纳入文献原文未报告。
临床应用与阅片要点
- 日常冠脉成像判读应认识现有技术主要显示斑块形态特征,尚不能可靠预测未来心梗。
局限性
- 原文未报告综述的检索范围与纳入文献,证据基础不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The majority of coronary atherothrombotic events presenting as myocardial infarction (MI) occur as a result of plaque rupture or erosion. Understanding the evolution from a stable plaque into a life-threatening, high-risk plaque is required for advancing clinical approaches to predict atherothrombotic events, and better treat coronary atherosclerosis. Unfortunately, none of the coronary imaging approaches used in clinical practice can reliably predict which plaques will cause an MI. Currently used imaging techniques mostly identify morphological features of plaques, but are not capable of detecting essential molecular characteristics known to be important drivers of future risk. To address this challenge, engineers, scientists, and clinicians have been working hand-in-hand to advance a variety of multimodality intravascular imaging techniques, whereby 2 or more complementary modalities are integrated into the same imaging catheter. Some of these have already been tested in early clinical studies, with other next-generation techniques also in development. This review examines these emerging hybrid intracoronary imaging techniques and discusses their strengths, limitations, and potential for clinical translation from both an engineering and clinical perspective.
引用
- Li J, Montarello NJ, Hoogendoorn A, et al. Multimodality Intravascular Imaging of High-Risk Coronary Plaque. JACC Cardiovasc Imaging. 2021. PMID: 34023267. doi:10.1016/j.jcmg.2021.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。